• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性耐甲氧西林金黄色葡萄球菌骨髓炎:采用联合抗生素治疗并通过血清杀菌效价进行评估。

Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.

作者信息

Aspinall S L, Friedland D M, Yu V L, Rihs J D, Muder R R

机构信息

Pharmacy Service, Veterans Affairs Medical Center, Pittsburgh, PA 15240, USA.

出版信息

Ann Pharmacother. 1995 Jul-Aug;29(7-8):694-7. doi: 10.1177/106002809502907-807.

DOI:10.1177/106002809502907-807
PMID:8520082
Abstract

OBJECTIVE

To report on a patient with recurrent methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis and bacteremia successfully treated with combination antibiotic therapy.

CASE SUMMARY

Two sets of blood cultures from a 55-year-old man with fever, malaise, and low back pain grew MRSA. Radiologic studies of the spine showed bony changes consistent with osteomyelitis. Soon after completing 6 weeks of vancomycin, the patient experienced a recurrence of back pain. Laboratory values included an increase in the sedimentation rate to 53 mm/h and positive blood cultures for MRSA. Vancomycin, gentamicin, and rifampin were administered for 8 weeks. Serum inhibitory and bactericidal titers were more than 1:1024 for both the peak and trough concentrations. Radiologic studies of the spine showed healing osteomyelitis. Two years after completion of antibiotic therapy, the infection has not recurred.

DISCUSSION

Antibiotic therapy alone was attempted because the patient was considered a risky surgical candidate. Serum inhibitory and bactericidal titers documented the high in vivo activity of the vancomycin, gentamicin, and rifampin combination. Initiation of vancomycin, gentamicin, and rifampin combination. Initiation of vancomycin therapy led to disappearance of the fever and back pain. Cure was documented by sustained normalization of the erythrocyte sedimentation rate and radiologic evidence of healing.

CONCLUSIONS

Combination antibiotic therapy with vancomycin, rifampin, and low-dose gentamicin (1 mg/kg q12h) may be useful for deep-seated tissue infection caused by MRSA.

摘要

目的

报告一例复发性耐甲氧西林金黄色葡萄球菌(MRSA)骨髓炎和菌血症患者经联合抗生素治疗成功治愈的病例。

病例摘要

一名55岁男性,有发热、乏力和腰痛症状,两套血培养结果均为MRSA生长。脊柱影像学检查显示骨质改变符合骨髓炎表现。在完成6周万古霉素治疗后不久,患者再次出现背痛。实验室检查结果包括血沉升至53mm/h以及MRSA血培养阳性。给予万古霉素、庆大霉素和利福平治疗8周。血清抑菌和杀菌效价在峰值和谷值浓度时均超过1:1024。脊柱影像学检查显示骨髓炎愈合。抗生素治疗完成两年后,感染未复发。

讨论

由于该患者被认为是手术高危候选人,因此首先尝试单独使用抗生素治疗。血清抑菌和杀菌效价证明了万古霉素、庆大霉素和利福平联合用药在体内具有较高活性。开始使用万古霉素治疗后,发热和背痛症状消失。红细胞沉降率持续正常化以及影像学愈合证据证明了治愈。

结论

万古霉素、利福平与低剂量庆大霉素(1mg/kg,每12小时一次)联合抗生素治疗可能对MRSA引起的深部组织感染有效。

相似文献

1
Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.复发性耐甲氧西林金黄色葡萄球菌骨髓炎:采用联合抗生素治疗并通过血清杀菌效价进行评估。
Ann Pharmacother. 1995 Jul-Aug;29(7-8):694-7. doi: 10.1177/106002809502907-807.
2
Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.利福平联合达托霉素治疗达托霉素中介耐甲氧西林金黄色葡萄球菌菌血症
Ann Pharmacother. 2010 May;44(5):918-21. doi: 10.1345/aph.1M665. Epub 2010 Mar 30.
3
Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis.万古霉素治疗与耐甲氧西林金黄色葡萄球菌性脊椎骨髓炎的进展
South Med J. 2004 Jun;97(6):593-7. doi: 10.1097/00007611-200406000-00017.
4
Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的血源性椎体骨髓炎的临床特征和治疗效果。
J Infect. 2013 Dec;67(6):556-64. doi: 10.1016/j.jinf.2013.07.026. Epub 2013 Jul 31.
5
Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.在兔模型中对替加环素和万古霉素(联合或不联合利福平)治疗耐甲氧西林金黄色葡萄球菌实验性骨髓炎的比较评价。
J Antimicrob Chemother. 2005 Jun;55(6):995-1002. doi: 10.1093/jac/dki109. Epub 2005 Apr 27.
6
Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.尽管使用万古霉素治疗后体温已退,但仍出现迁延性和复发性耐甲氧西林金黄色葡萄球菌菌血症。
Scand J Infect Dis. 1995;27(5):529-32. doi: 10.3109/00365549509047061.
7
Reactivation of dormant lumbar methicillin-resistant Staphylococcus aureus osteomyelitis after 12 years.潜伏12年的耐甲氧西林金黄色葡萄球菌性腰椎骨髓炎复发
J Clin Neurosci. 2007 Jun;14(6):585-9. doi: 10.1016/j.jocn.2005.12.006. Epub 2006 Dec 22.
8
A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. stewardship 项目回顾性评估耐甲氧西林金黄色葡萄球菌菌血症和骨髓炎患者的万古霉素 AUC24/MIC 和微生物学清除时间。
Clin Ther. 2013 Jun;35(6):772-9. doi: 10.1016/j.clinthera.2013.05.008.
9
Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.口服降阶梯疗法治疗金黄色葡萄球菌骨髓炎与静脉治疗效果相当。
J Infect. 2007 Jun;54(6):539-44. doi: 10.1016/j.jinf.2006.11.011. Epub 2007 Jan 2.
10
Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.在治疗药物监测下,使用利奈唑胺和利福平联合治疗耐甲氧西林金黄色葡萄球菌骨髓炎取得成功。
J Infect Chemother. 2016 May;22(5):331-4. doi: 10.1016/j.jiac.2015.11.012. Epub 2015 Dec 28.

引用本文的文献

1
Comparison of clinical features and outcomes of staphylococcus aureus vertebral osteomyelitis caused by methicillin-resistant and methicillin-sensitive strains.耐甲氧西林和甲氧西林敏感菌株所致金黄色葡萄球菌性脊椎骨髓炎的临床特征及结局比较
Springerplus. 2013 Jun 27;2(1):283. doi: 10.1186/2193-1801-2-283. Print 2013 Dec.
2
Rifampin combination therapy for nonmycobacterial infections.利福平联合疗法治疗非分枝杆菌感染。
Clin Microbiol Rev. 2010 Jan;23(1):14-34. doi: 10.1128/CMR.00034-09.